SOW
EGRX

State of Wyoming’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

State of Wyoming’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,118
Closed -$45.5K – 1945
2024
Q2 		$45.5K Sell
8,118
-13,531
-63% -$58.9K 0.01% 1342
2024
Q1 		$113K Buy
+21,649
New +$119K 0.02% 926
2022
Q4 		– Sell
-516
Closed -$14K – 1796
2022
Q3 		$14K Buy
516
+114
+28% +$4.18K 0.01% 1402
2022
Q2 		$18K Sell
402
-943
-70% -$43.3K 0.01% 1482
2022
Q1 		$67K Sell
1,345
-538
-29% -$25.8K 0.03% 881
2021
Q4 		$96K Buy
+1,883
New +$97.6K 0.04% 669

Other funds holding EGRX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State of Wyoming's EGRX Position: Q3 2024 in Review

State of Wyoming sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q3 2024, closing a stake of 8,118 shares — an estimated $45.5K sold.

State of Wyoming first reported a position in EGRX in Q4 2021 and held it in 6 quarters. The position peaked at $113K in Q1 2024. 65 funds tracked by Wall St. Rank hold EGRX as of Q3 2024.

  • State of Wyoming reported no remaining Eagle Pharmaceuticals, Inc. position as of Q3 2024 after selling out during the quarter.
  • State of Wyoming sold 8,118 Eagle Pharmaceuticals, Inc. shares in Q3 2024, an estimated $45.5K.
  • State of Wyoming first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2021 and held it in 6 quarters.
  • State of Wyoming's Eagle Pharmaceuticals, Inc. position peaked at $113K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q3 2024.

Based on State of Wyoming's 13F filing for Q3 2024, filed 14 Nov 2024.